| Long-term effect of diabetes and its treatment on cognitive function DERG Jacobson AM, Ryan CM, Cleary P, Waberski BH, Burwood A, Weinger K ... N Engl J Med 356, 1842-52, 2007 | 786* | 2007 |
| Neuropathy among the Diabetes Control and Complications Trial (DCCT) cohort 8 years after trial completion DERG Martin CL, Albers J, Herman WH, Cleary P, Waberski BH, Greene DA ... Diabetes Care 29, 340-44, 2006 | 575 | 2006 |
| Use of the Michigan Neuropathy Screening Instrument (MNSI) as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the Diabetes Control and … DERG Herman WH, Pop-Busui R, Braffett BH, Martin CL, Cleary PA, Albers JW ... Diabet Med 29, 937-44, 2012 | 565 | 2012 |
| Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of … DERG Albers JW, Herman WH, Pop-Busui R, Feldman EL, Martin CL, Cleary PA ... Diabetes Care 33, 1090-6, 2010 | 489 | 2010 |
| Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology … DERG Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL ... Circulation 119, 2886-93, 2009 | 391 | 2009 |
| Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC cohort NR Chen Z, Miao F, Paterson AD, Lachin JM, Zhang L, Riggs AD, Schones D, Wu ... Proc Natl Acad Sci 113, E3002-11, 2016 | 245* | 2016 |
| The long-term effects of type 1 diabetes treatment and complications on health-related quality-of-life: a 23 year follow-up of the Diabetes Control and Complications Trial … DERG Jacobson AM, Braffett BH, Cleary PA, Gubitosi-Klug RA, Larkin ME Diabetes Care 36, 3131-8, 2013 | 206 | 2013 |
| Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the DCCT cohort DERG Jacobson AM, Ryan CM, Cleary PS, Waberski BH, Weinger K, Musen G, Dahms W Diabetologia 54, 245-55, 2011 | 205* | 2011 |
| Risk factors for diabetic peripheral neuropathy and cardiovascular autonomic neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions … DERG Braffett BH, Gubitosi-Klug RA, Albers JA, Feldman EL, Martin CL, White ... Diabetes 69 (5), 1000-1010, 2020 | 178 | 2020 |
| Risk factors for cardiovascular disease in type 1 diabetes DERG Nathan DM, Bebu I, Braffett BH, Orchard TJ, Cowie CC, Lopes-Virella M ... Diabetes 65, 1370-9, 2016 | 169* | 2016 |
| DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history DERG Pop-Busui R, Herman WH, Feldman EL, Low PA, Martin CL, Cleary PA ... Curr Diab Rep 10, 276-82, 2010 | 169 | 2010 |
| Musculoskeletal complications in type 1 diabetes DERG Larkin ME, Barnie A, Braffett BH, Cleary PA, Diminick L, Harth J ... Diabetes Care 37, 1863-69, 2014 | 160 | 2014 |
| The risk of severe hypoglycemia in type 1 diabetes over 30 years of follow-up in the DCCT/EDIC study DERG Gubitosi-Klug RA, Braffett BH, White N, Sherwin RS, Service JF, Lachin ... Diabetes Care 40, 1010-16, 2017 | 148 | 2017 |
| Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial DERG Musen G, Jacobson AM, Ryan CM, Cleary PA, Waberski BH, Weinger K, Dahms ... Diabetes Care 31, 1933-38, 2008 | 145 | 2008 |
| Cardiovascular autonomic neuropathy and cardiovascular outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT … DERG Pop-Busui R, Braffett BH, Zinman B, Martin C, White NH, Herman WH ... Diabetes Care 40, 94-100, 2017 | 129 | 2017 |
| Extending the preoxygenation period from 4 to 8 mins in critically ill patients undergoing emergency intubation CJ Mort TC, Waberski BH Crit Care Med 37, 68-71, 2009 | 126 | 2009 |
| Effect of excessive weight gain on cardiovascular outcomes in type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions … DERG Purnell JQ, Braffett BH, Zinman B, Gubitosi-Klug RA, Sivitz W, Bantle ... Diabetes Care 40, 1756-62, 2017 | 116 | 2017 |
| Association between cardiovascular autonomic neuropathy and left ventricular dysfunction in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions … DERG Pop-Busui R, Cleary PA, Braffett BH, Martin CL, Herman WH, Low PA, Lima ... J Am Coll Cardiol 61, 447-54, 2013 | 112* | 2013 |
| Vibration Perception Threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the Diabetes Control and Complications Trial … DERG Martin CL, Waberski BH, Pop-Busui R, Cleary PA, Catton S, Albers JW ... Diabetes Care 33, 2635-41, 2010 | 110 | 2010 |
| Risk factors for first and subsequent CVD events in type 1 diabetes: the DCCT/EDIC study DERG Bebu I, Schade D, Braffett BH, Kosiborod M, Lopes-Virella M, Soliman EZ ... Diabetes Care 43 (4), 867-874, 2020 | 94 | 2020 |